or Try an Advanced Search...

    Technical Analysis for RVMD - Revolution Medicines, Inc.

    Grade Last Price % Change Price Change
    A 35.96 1.78% 0.63
    RVMD closed up 1.78 percent on Friday, April 26, 2024, on 78 percent of normal volume.
    Earnings due: May 6
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Flat
    Historical RVMD trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    MACD Bearish Signal Line Cross Bearish 1.78%
    NR7 Range Contraction 1.78%
    NR7-2 Range Contraction 1.78%
    Down 3 Days in a Row Weakness 1.78%
    Gapped Down Weakness 1.78%
    NR7 Range Contraction 1.04%
    Shooting Star Candlestick Bearish -0.83%
    Wide Bands Range Expansion -1.29%
    Wide Bands Range Expansion 2.98%
    Older End-of-Day Signals for RVMD ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 17 hours ago
    Rose Above 10 DMA about 21 hours ago
    Up 2% about 21 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    Rose Above Previous Day's High about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    RVMD Chart by TradingView
    Basic chart:

    Profile

    Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Clinical Medicine Cancer Treatment Pharmacology Signal Transduction mTOR Ras Gtpase Combination Therapy

    Is RVMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 12 Top 3 Health Care Stocks That May Collapse In Q2
    Apr 12 Revolution Medicines: An Expensive Shot At A Massive Market Opportunity
    Apr 10 Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
    Apr 9 Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
    Apr 8 Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
    Mar 28 Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
    Mar 5 Revolution Medicines files for mixed shelf offering
    Feb 28 Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript
    Feb 28 Revolution Medicines Full Year 2023 Earnings: Misses Expectations
    Feb 27 Q4 2023 Revolution Medicines Inc Earnings Call
    See more RVMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 38.73
    52 Week Low 15.46
    Average Volume 1,548,375
    200-Day Moving Average 28.46
    50-Day Moving Average 32.27
    20-Day Moving Average 34.46
    10-Day Moving Average 35.89
    Average True Range 1.71
    RSI (14) 58.51
    ADX 30.58
    +DI 28.54
    -DI 17.64
    Chandelier Exit (Long, 3 ATRs) 33.61
    Chandelier Exit (Short, 3 ATRs) 34.67
    Upper Bollinger Bands 39.07
    Lower Bollinger Band 29.85
    Percent B (%b) 0.66
    BandWidth 26.73
    MACD Line 1.18
    MACD Signal Line 1.24
    MACD Histogram -0.0591
    Fundamentals Value
    Market Cap 5.89 Billion
    Num Shares 164 Million
    EPS -3.26
    Price-to-Earnings (P/E) Ratio -11.03
    Price-to-Sales 192.04
    Price-to-Book 5.95
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 38.53
    Resistance 3 (R3) 38.37 37.37 38.10
    Resistance 2 (R2) 37.37 36.71 37.44 37.95
    Resistance 1 (R1) 36.66 36.31 37.02 36.82 37.81
    Pivot Point 35.66 35.66 35.83 35.73 35.66
    Support 1 (S1) 34.95 35.00 35.31 35.11 34.11
    Support 2 (S2) 33.95 34.60 34.02 33.97
    Support 3 (S3) 33.24 33.95 33.82
    Support 4 (S4) 33.40